Supplies - 351227-2022

29/06/2022    S123

Norway-Vadsø: Laboratory, optical and precision equipments (excl. glasses)

2022/S 123-351227

Prior information notice

This notice is for prior information only


Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
National registration number: 916879067
Postal address: Postboks 40
NUTS code: NO Norge
Postal code: 9811
Country: Norway
Internet address(es):
Main address:
Address of the buyer profile:
I.2)Information about joint procurement
The contract is awarded by a central purchasing body
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity

Section II: Object

II.1)Scope of the procurement

Invitation to a market dialogue - innovation partnership, dried blood plasma

Reference number: 2021/156
II.1.2)Main CPV code
38000000 Laboratory, optical and precision equipments (excl. glasses)
II.1.3)Type of contract
II.1.4)Short description:

Helse Bergen would lik to have a dialogue with interested parties in the market that would like to participate in the development of a system for drying blood plasma used to treat patients with life-threatening bleeding.

Helse Bergen has up to NOK 13.5 million that will be used for the development of an innovative system for the production of dried blood plasma for use in the treatment of patients with life-threatening bleeding.

The resources have been granted from Innovasjon Norge and Helse Bergen will make a procurement in accordance with the procedure for an innovation partnership. 

II.1.5)Estimated total value
II.1.6)Information about lots
This contract is divided into lots: no
II.2.2)Additional CPV code(s)
33141510 Blood products
33141613 Blood bags
33793000 Laboratory glassware
51430000 Installation services of laboratory equipment
II.2.3)Place of performance
NUTS code: NO0A2 Vestland
Main site or place of performance:


II.2.4)Description of the procurement:

We will present our need for more efficient and predictable access to this vital product, which is absolutely vital in many different acute situations. Furthermore, we would like input from companies on the proposal for solutions and interest in a cooperation on such a solution - either with individual suppliers or through a cooperation between several suppliers. The aim of the market dialogue is to clarify whether potential suppliers have understood our needs and to see the feasibility for solutions and any challenges in the project. Input from the market at the dialogue conference will form the basis for the preparation of the tender documentation and final needs description, the aim and functional requirements.Input from the market at the dialogue conference will form the basis for the documentation and the description of the final challenges, the goals and functional requirements.

Target group: Potential suppliers of innovative solutions that can contribute to solving the challenge by producing dried blood plasma. This includes developers of technology for drying blood plasma, manufacturers or packaging, developers of IT systems, and design competence.

See the attached invitation to a market dialogue for further details on the need and how the dialogue conference will be held. 

II.2.14)Additional information

The procurement will be made in accordance with the PPR Part III and the procedure for an innovation partnership.

II.3)Estimated date of publication of contract notice:

Section IV: Procedure

IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes

Section VI: Complementary information

VI.3)Additional information:

A link to the registration for the dialogue conference is in the invitation.

VI.5)Date of dispatch of this notice: